Growing awareness campaigns regarding weight management is expected to drive growth of the global orlistat market during the forecast period. For instance, in 2013, Roche Holding AG, a pharmaceutical company, launched its new campaign ‘New You Weight Consciousness Advocacy Campaign’, which was intended to increase awareness among the populace regarding obesity and its treatment options. Thus, such awareness campaigns are expected boost the adoption of weight management medication treatments, which in turn, is expected to propel growth of the global orlistat market size.
Request for Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1878
Key products in the market are adopting market strategies such as collaborations and partnerships to re-launch their products, which is expected to boost the market in the near future. For instance, in February 2018, H2 Pharma, LLC partnered with Cheplapharma Arzneimittel GmbH and re-launched Xenical Capsules, which was acquired from F.Hoffman-La Roche. Xenical capsules were re-launched to increase awareness regarding medication related to weight management, this in turn, is expected to boost orlistat market growth.
Moreover, robust medications pipeline by key market players is expected to boost the market growth over the forecast period. For instance, orlistat by University of Texas South Western Medical center is in phase 2 since 2015. Orlistat is used for the treatment of hyperlipoproteinemia type 1. Hyperlipoproteinemia type 1 is caused due to deficiency of lipoprotein lipase. SLx-4090 by University of Texas South Western Medical center is in phase 2 to study its effectiveness in combination with Orlistat. SLx-4090 is used to treat high blood fat level mostly observed in hyperlipoproteinemia type 1 patients.
Growing prevalence of obesity is expected to boost the global orlistat market growth. According to National Family Health Survey, 2015, in India, over 9.8 million men and over 20 million women were recorded to be obese. According to the same souce, India stands as the second-highest in the world for obese children, with the number constantly increasing by 3-5 million patients every year.
Apply Promo Code “STAYHOME” and Get Instant Discount of USD 1000
If you purchase the report this year:
Flat 20% instant discount
25% discount on 2nd report
15 % free customization
Buy This Complete A Business Report @: https://www.coherentmarketinsights.com/insight/buy-now/1878
Key players operating in the Global orlistat market include Roche Holding AG, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd, Sandoz Pharmaceuticals, STADA–VN J.V. Co., Ltd., Hexal AG., National Company for Pharmaceutical Industry, Lunan Pharmaceutical group Corporation Ltd., ZEIN Pharmaceutical Co. Ltd., HISUN Pharmaceuticals Co. Ltd., Taj Pharmaceuticals Ltd., D.M. Pharma, China Zhongshan Pharma Co. Ltd., and Kabir Life Sciences and Research Pvt. Ltd.
Direct Line: +1-206-701-6702 (US)